Human Tetanus Immunoglobulin

Introduction

Human Tetanus Immunoglobulin (HTIG) is a preparation of pooled human immunoglobulins that contains antibodies against tetanus toxin. It is used as a passive immunization to prevent or treat tetanus infections in individuals who have been exposed to the tetanus bacterium or who are at high risk of tetanus.

Uses

Human Tetanus Immunoglobulin is used for:

• Post-exposure prophylaxis in individuals who have not been adequately vaccinated against tetanus or whose vaccination status is unknown, especially after a tetanus-prone wound.
• Treatment of tetanus infection, in conjunction with tetanus toxoid vaccination and appropriate wound management.
• Providing immediate but temporary immunity in cases where active immunization with tetanus toxoid is not possible.

Mechanism of Action

Human Tetanus Immunoglobulin provides passive immunity by supplying antibodies against the tetanus toxin. These antibodies neutralize the toxin and prevent its binding to nerve endings, thus preventing the progression of tetanus and aiding in the resolution of the infection.

How Long Does It Take to Work?

The effects of Human Tetanus Immunoglobulin are typically immediate, providing prompt protection against the tetanus toxin. However, it is used in conjunction with tetanus toxoid to provide long-term immunity.

Absorption

Human Tetanus Immunoglobulin is administered intramuscularly, and its components are rapidly absorbed into the bloodstream.

Route of Elimination

The antibodies in Human Tetanus Immunoglobulin are gradually broken down by the body, with their elimination primarily occurring through the reticuloendothelial system. The half-life of these immunoglobulins varies but is generally around 2-3 weeks.

Dosage

• For adults and children single dose of 250 IU should be given. The dose may be increased to 500 IU in case of:
• Infected wounds where surgically appropriate treatment cannot be achieved within 24 hours
• Deep or contaminated wounds with tissue damage and reduced oxygen supply, as well as foreign body injury (e.g., bites, stings or shots)
• Burns, congelations
• Tissue necrosis
• Septicaemic abortion
• Adults weighing more than the average

The dosage of Human Tetanus Immunoglobulin depends on the clinical situation and the patient's exposure history:

• For post-exposure prophylaxis: Typically, 250 units administered intramuscularly as a single dose.
• For treatment of tetanus: Dosage may be higher and is tailored to the severity of the infection and patient needs.

Administration

Human Tetanus Immunoglobulin is administered intramuscularly, usually in the deltoid muscle. It should be given as soon as possible after exposure to tetanus or in the presence of a tetanus-prone wound.

Side Effects

Common side effects may include:

• Local reactions at the injection site, such as pain, swelling, or redness.
• Mild fever.
• Allergic reactions, though rare.

Toxicity

Human Tetanus Immunoglobulin is generally well-tolerated. Toxicity is rare but may include severe allergic reactions or anaphylaxis. In such cases, immediate medical attention is required.

Precautions

Precautions include:

• Monitor for allergic reactions, especially in patients with a history of hypersensitivity to immunoglobulins.
• Use with caution in patients with a history of severe adverse reactions to previous doses of immunoglobulins.

Interaction

Human Tetanus Immunoglobulin should be used in conjunction with tetanus toxoid to ensure effective immunization. It may interfere with the immune response to live vaccines if given simultaneously or within a short time frame.

Disease Interaction

Use with caution in patients with autoimmune disorders or immunodeficiencies, as their immune response may be compromised.

Drug Interaction

Human Tetanus Immunoglobulin may interact with live vaccines. It is advisable to separate the administration of immunoglobulins and live vaccines by several weeks.

Food Interactions

There are no known food interactions with Human Tetanus Immunoglobulin. Patients can maintain a normal diet.

Pregnancy Use

Human Tetanus Immunoglobulin is generally considered safe during pregnancy. It is used when indicated to protect both the mother and fetus from tetanus exposure.

Lactation Use

Human Tetanus Immunoglobulin is also considered safe for use during lactation. It does not affect breastfeeding or the infant adversely.

Acute Overdose

Acute overdose is unlikely due to the controlled dosing of Human Tetanus Immunoglobulin. If an excessive amount is administered, it may lead to increased risk of side effects, such as severe allergic reactions.

Contraindication

Contraindications include:

• Known hypersensitivity to immunoglobulins or any component of the preparation.
• History of severe allergic reactions to previous doses.

Use Direction

Administer Human Tetanus Immunoglobulin intramuscularly as directed by a healthcare provider. Follow the recommended dosage and administration schedule, and ensure it is given promptly after exposure to tetanus or in a tetanus-prone situation.

Storage Conditions

Store Human Tetanus Immunoglobulin in a refrigerator at 2-8°C (36-46°F). Do not freeze. Keep it out of reach of children and protect it from light.

Volume of Distribution

The volume of distribution for immunoglobulins is generally around 5-7 liters in the human body. Specific values for Human Tetanus Immunoglobulin are not typically detailed.

Half Life

The half-life of Human Tetanus Immunoglobulin is approximately 2-3 weeks. This duration may vary based on individual patient factors and response to treatment.

Clearance

Human Tetanus Immunoglobulin is cleared from the bloodstream gradually through the reticuloendothelial system, with the rate of clearance depending on the individual’s metabolism and immune response.